keyword
MENU ▼
Read by QxMD icon Read
search

Microbiome IBS

keyword
https://www.readbyqxmd.com/read/30294792/systematic-review-with-meta-analysis-the-efficacy-of-prebiotics-probiotics-synbiotics-and-antibiotics-in-irritable-bowel-syndrome
#1
REVIEW
Alexander C Ford, Lucinda A Harris, Brian E Lacy, Eamonn M M Quigley, Paul Moayyedi
BACKGROUND: Irritable bowel syndrome (IBS) is a chronic functional bowel disorder. Disturbances in the gastrointestinal microbiome may be involved in its aetiology. AIM: To perform a systematic review and meta-analysis to examine the efficacy of prebiotics, probiotics, synbiotics and antibiotics in IBS. METHODS: MEDLINE, EMBASE, and the Cochrane Controlled Trials Register were searched (up to July 2017). Randomised controlled trials (RCTs) recruiting adults with IBS, comparing prebiotics, probiotics, synbiotics or antibiotics with placebo or no therapy were eligible...
October 8, 2018: Alimentary Pharmacology & Therapeutics
https://www.readbyqxmd.com/read/30288077/the-role-of-inflammation-in-irritable-bowel-syndrome-ibs
#2
REVIEW
Qin Xiang Ng, Alex Yu Sen Soh, Wayren Loke, Donovan Yutong Lim, Wee-Song Yeo
Irritable bowel syndrome (IBS) is a complex, functional gastrointestinal disorder characterized by chronic abdominal pain or discomfort and altered bowel habits. Despite the global prevalence and disease burden of IBS, its underlying pathophysiology remains unclear. Inflammation may play a pathogenic role in IBS. Studies have highlighted the persistence of mucosal inflammation at the microscopic and molecular level in IBS, with increased recruitment of enteroendocrine cells. Substantial overlaps between IBS and inflammatory bowel disease have also been reported...
2018: Journal of Inflammation Research
https://www.readbyqxmd.com/read/30189148/antibiotics-a-risk-factor-for-irritable-bowel-syndrome-in-a-population-based-cohort
#3
Laura Rindom Krogsgaard, Anne Line Engsbro, Peter Bytzer
OBJECTIVES: Use of antibiotics affects the composition of the gut microbiome. The microbiome is thought to play a role in development of irritable bowel syndrome (IBS), but antibiotics as a possible risk factor for IBS has not been clarified. We aimed to explore if antibiotics is a risk factor for IBS by investigating use of antibiotics and development of IBS in a cohort from the Danish background population. MATERIALS AND METHODS: An internet-based web panel representative of the Danish background population was invited to participate in a survey regarding the epidemiology of IBS in 2010, 2011 and 2013...
September 6, 2018: Scandinavian Journal of Gastroenterology
https://www.readbyqxmd.com/read/30148765/relationships-of-microbiome-markers-with-extraintestinal-psychological-distress-and-gastrointestinal-symptoms-and-quality-of-life-in-women-with-irritable-bowel-syndrome
#4
Emily B Hollister, Kevin C Cain, Robert J Shulman, Monica E Jarrett, Robert L Burr, Cynthia Ko, Jasmine Zia, Claire J Han, Margaret M Heitkemper
INTRODUCTION: Altered microbial diversity has been associated with gastrointestinal (GI) symptoms in persons with irritable bowel syndrome (IBS). Less is known about the relationship of microbiome with extraintestinal pain and psychological distress symptoms and quality of life (QOL) in persons with IBS. We aimed to evaluate the relationship of fecal microbiota to GI symptoms, stool consistency, psychological distress, extraintestinal pain, and QOL in participants meeting Rome III criteria for IBS...
August 24, 2018: Journal of Clinical Gastroenterology
https://www.readbyqxmd.com/read/30136337/the-effect-of-a-multispecies-probiotic-on-microbiota-composition-in-a-clinical-trial-of-patients-with-diarrhea-predominant-irritable-bowel-syndrome
#5
Keren Hod, Roy Dekel, Nathaniel Aviv Cohen, Ami Sperber, Yishai Ron, Mona Boaz, Shlomo Berliner, Nitsan Maharshak
BACKGROUND: Although probiotics are increasingly used in irritable bowel syndrome (IBS), their mechanism of action has not been elucidated sufficiently. We aimed to evaluate the impact of a multispecies probiotic on enteric microbiota composition in women with diarrhea-predominant-IBS (IBS-D) and to determine whether these effects are associated with changes in IBS symptoms or inflammatory markers. METHODS: In a double-blind, placebo-controlled study, Rome III IBS-D women completed a two-week run-in period and eligible women were assigned at random to a probiotic capsule (BIO-25) or an indistinguishable placebo, twice daily for 8 weeks...
August 23, 2018: Neurogastroenterology and Motility: the Official Journal of the European Gastrointestinal Motility Society
https://www.readbyqxmd.com/read/30026921/the-gut-microbiome-and-irritable-bowel-syndrome
#6
REVIEW
Stacy Menees, William Chey
Irritable bowel syndrome (IBS) is one of the most common functional gastrointestinal disorders encountered in clinical practice. It is a heterogeneous disorder with a multifactorial pathogenesis. Recent studies have demonstrated that an imbalance in gut bacterial communities, or "dysbiosis", may be a contributor to the pathophysiology of IBS. There is evidence to suggest that gut dysbiosis may lead to activation of the gut immune system with downstream effects on a variety of other factors of potential relevance to the pathophysiology of IBS...
2018: F1000Research
https://www.readbyqxmd.com/read/30009817/rome-foundation-working-team-report-on-post-infection-irritable-bowel-syndrome
#7
Giovanni Barbara, Madhusudan Grover, Premysl Bercik, Maura Corsetti, Uday C Ghoshal, Lena Ohman, Mirjana Rajilić-Stojanović
BACKGROUND & AIMS: The existence of post-infection irritable bowel syndrome (PI-IBS) has been substantiated by epidemiology studies conducted in diverse geographic and clinical settings. However, the available evidence has not been well summarized and there is little guidance for diagnosis and treatment of PI-IBS. The ROME Foundation has produced a working team report was to summarize the available evidence on the pathophysiology of PI-IBS and provide guidance for diagnosis and treatment, based upon findings reported in the literature and clinical experience...
July 12, 2018: Gastroenterology
https://www.readbyqxmd.com/read/29935865/the-gut-microbiome-and-irritable-bowel-syndrome-state-of-art-review
#8
REVIEW
Ahmed E Salem, Rajdeep Singh, Younan K Ayoub, Ahmed M Khairy, Gerard E Mullin
Irritable bowel syndrome (IBS) is a functional disorder of the gastrointestinal tract, the physiology of which is not very well understood. There are multiple factors and pathways involved in pathogenesis of this entity. Among all, dysmotility, dysregulation of the brain-gut axis, altered intestinal microbiota and visceral hypersensitivity play a major role. Over the last years, research has shown that the type of gut microbiome present in an individual plays a significant role in the pathophysiology of IBS...
June 20, 2018: Arab Journal of Gastroenterology: the Official Publication of the Pan-Arab Association of Gastroenterology
https://www.readbyqxmd.com/read/29915224/characteristics-of-the-bacterial-microbiome-in-association-with-common-intestinal-parasites-in-irritable-bowel-syndrome
#9
Laura Rindom Krogsgaard, Lee O 'Brien Andersen, Thor Bech Johannesen, Anne Line Engsbro, Christen Rune Stensvold, Henrik Vedel Nielsen, Peter Bytzer
OBJECTIVE: A low prevalence of intestinal parasites has been identified in individuals with irritable bowel syndrome (IBS), but potential associations with alterations in the bacterial microbiome remain largely unexplored. We aimed to investigate the relationship between parasites and bacteria in individuals with IBS in order to identify potential trans-kingdom microbial characteristics. DESIGN: Stool samples were collected from the Danish background population classified into IBS (n = 119), unspecific gastrointestinal (GI) symptoms (n = 114), and asymptomatic controls (n = 186) based on the Rome III criteria for IBS...
June 19, 2018: Clinical and Translational Gastroenterology
https://www.readbyqxmd.com/read/29876777/probiotics-ameliorate-stool-consistency-in-patients-with-chronic-constipation-a-randomized-double-blind-placebo-controlled-study
#10
Jin Young Yoon, Jae Myung Cha, Ju Kyoung Oh, Pei Lei Tan, Sae Hun Kim, Min Seob Kwak, Jung Won Jeon, Hyun Phil Shin
BACKGROUND/AIMS: The efficacy of probiotics for improving clinical symptoms, altering the fecal microbiota, and regulating serum immune cytokine levels was investigated in patients with irritable bowel syndrome-constipation (IBS-C) or functional constipation (FC). METHODS: A randomized, double-blind, placebo-controlled trial was conducted at Kyung Hee University Hospital between October 2016 and February 2017. Consecutive 18-75-year-old patients with diagnosis of IBS-C or FC (based on Rome IV criteria) consumed probiotics (3...
June 7, 2018: Digestive Diseases and Sciences
https://www.readbyqxmd.com/read/29777439/fecal-and-mucosa-associated-intestinal-microbiota-in-patients-with-diarrhea-predominant-irritable-bowel-syndrome
#11
Nitsan Maharshak, Yehuda Ringel, David Katibian, Ashley Lundqvist, R Balfour Sartor, Ian M Carroll, Tamar Ringel-Kulka
BACKGROUND: Irritable bowel syndrome (IBS) has been associated with changes in the intestinal microbiota. Only a few studies have explored differences in the mucosa-associated microbiota between IBS patients and healthy controls (HC). AIMS: To characterize and compare the microbiota in mucosal and fecal samples from carefully selected patients with IBS-D and HC. METHODS: The cohort was composed of 23 diarrhea-predominant IBS (IBS-D) patients and 24 HC...
July 2018: Digestive Diseases and Sciences
https://www.readbyqxmd.com/read/29748817/the-role-of-the-microbiome-for-human-health-from-basic-science-to-clinical-applications
#12
M Hasan Mohajeri, Robert J M Brummer, Robert A Rastall, Rinse K Weersma, Hermie J M Harmsen, Marijke Faas, Manfred Eggersdorfer
The 2017 annual symposium organized by the University Medical Center Groningen in The Netherlands focused on the role of the gut microbiome in human health and disease. Experts from academia and industry examined interactions of prebiotics, probiotics, or vitamins with the gut microbiome in health and disease, the development of the microbiome in early-life and the role of the microbiome on the gut-brain axis. The gut microbiota changes dramatically during pregnancy and intrinsic factors (such as stress), in addition to extrinsic factors (such as diet, and drugs) influence the composition and activity of the gut microbiome throughout life...
May 10, 2018: European Journal of Nutrition
https://www.readbyqxmd.com/read/29668957/no-significant-association-between-the-fecal-microbiome-and-the-presence-of-irritable-bowel-syndrome-type-symptoms-in-patients-with-quiescent-inflammatory-bowel-disease
#13
Oliver Shutkever, David J Gracie, Caroline Young, Henry M Wood, Morag Taylor, P John Hamlin, Alexander C Ford, Philip Quirke
Background: The microbiome is implicated in the pathogenesis of inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). Whether a distinct microbiome profile is associated with the reporting of IBS-type symptoms in IBD patients is uncertain. We aimed to resolve this issue using a cross-sectional study design. Methods: Using clinical disease activity indices, the Rome III criteria for IBS and fecal calprotectin levels, we divided IBD patients into 4 groups: IBS-type symptoms, quiescent disease, occult inflammation, and active disease...
June 8, 2018: Inflammatory Bowel Diseases
https://www.readbyqxmd.com/read/29493330/fecal-microbiota-transplantation-for-managing-irritable-bowel-syndrome
#14
REVIEW
Magdy El-Salhy, Tarek Mazzawi
Irritable bowel syndrome (IBS) is a widespread gastrointestinal disorder affecting 11.2% of the world adult population. The intestinal microbiome is thought to play a pivotal role in the pathophysiology of IBS. The composition of the fecal microbiome in IBS patients differs from that in healthy individuals, but the exact bacteria species involved in the development of IBS remain to be determined. There is also an imbalance between useful and harmful bacteria (dysbiosis) in the intestinal microbiome in patients with IBS...
May 2018: Expert Review of Gastroenterology & Hepatology
https://www.readbyqxmd.com/read/29388674/pain-self-management-plus-nurse-led-support-in-young-adults-with-irritable-bowel-syndrome-study-protocol-for-a-pilot-randomized-control-trial
#15
RANDOMIZED CONTROLLED TRIAL
Xiaomei Cong, Divya Ramesh, Mallory Perry, Wanli Xu, Katherine M Bernier, Erin E Young, Stephen Walsh, Angela Starkweather
Irritable bowel syndrome (IBS) is a functional gut disorder that typically manifests in early adult years. IBS patients report that pain is the most distressing symptom with the greatest impact on quality of life. Pain-sensitivity genes and the gut microbiome may influence severity of symptoms as well as response to self-management (SM) interventions. Based on current understanding of the science of SM, pain neurophysiology, and the gut-brain axis, our team developed a pain SM intervention to be added to evidence-based self-management instruction to increase the individual's SM knowledge and skills (self-efficacy, self-regulation, and goal-setting)...
April 2018: Research in Nursing & Health
https://www.readbyqxmd.com/read/29383802/reversal-of-visceral-hypersensitivity-in-rat-by-menthacarin-%C3%A2-a-proprietary-combination-of-essential-oils-from-peppermint-and-caraway-coincides-with-mycobiome-modulation
#16
S Botschuijver, O Welting, E Levin, D Maria-Ferreira, E Koch, R C Montijn, J Seppen, T B M Hakvoort, F H J Schuren, W J de Jonge, R M van den Wijngaard
BACKGROUND: Irritable bowel syndrome (IBS) is a common gastrointestinal disorder associated with altered gastrointestinal microflora and increased nociception to colonic distension. This visceral hypersensitivity can be reversed in our rat maternal separation model by fungicides. Menthacarin® is a proprietary combination of essential oils from Mentha x piperita L. and Carum carvi. Because these oils exhibit antifungal and antibacterial properties, we investigated whether Menthacarin® can reverse existing visceral hypersensitivity in maternally separated rats...
June 2018: Neurogastroenterology and Motility: the Official Journal of the European Gastrointestinal Motility Society
https://www.readbyqxmd.com/read/29375937/eukaryotes-in-the-gut-microbiota-in-myalgic-encephalomyelitis-chronic-fatigue-syndrome
#17
Alexandra H Mandarano, Ludovic Giloteaux, Betsy A Keller, Susan M Levine, Maureen R Hanson
Patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) often suffer from gastrointestinal symptoms and many are diagnosed with irritable bowel syndrome (IBS). Previous studies, including from our laboratory, have demonstrated that the ME/CFS gut bacterial composition is altered and less diverse when compared to healthy individuals. Patients have increased biomarkers of inflammation and leaky gut syndrome. To further investigate dysbiosis in the ME/CFS gut microbiome, we sought to characterize the eukaryotes present in the gut of 49 individuals with ME/CFS and 39 healthy controls...
2018: PeerJ
https://www.readbyqxmd.com/read/29373532/the-role-of-bacteria-probiotics-and-diet-in-irritable-bowel-syndrome
#18
REVIEW
Ashton Harper, Malwina M Naghibi, Davinder Garcha
Irritable bowel syndrome is a highly prevalent gastrointestinal disorder that threatens the quality of life of millions and poses a substantial financial burden on healthcare systems around the world. Intense research into the human microbiome has led to fascinating discoveries which directly and indirectly implicate the diversity and function of this occult organ in irritable bowel syndrome (IBS) pathophysiology. The benefit of manipulating the gastrointestinal microbiota with diet and probiotics to improve symptoms has been demonstrated in a wealth of both animal and human studies...
January 26, 2018: Foods (Basel, Switzerland)
https://www.readbyqxmd.com/read/29301380/the-gut-brain-axis-and-the-microbiome-clues-to-pathophysiology-and-opportunities-for-novel-management-strategies-in-irritable-bowel-syndrome-ibs
#19
REVIEW
Eamonn M M Quigley
Irritable bowel syndrome (IBS) is one of the most common of all medical disorders worldwide and, while for some it represents no more than a nuisance, for others it imposes significant negative impacts on daily life and activities. IBS is a heterogeneous disorder and may well have a number of causes which may lie anywhere from the external environment to the contents of the gut lumen and from the enteric neuromuscular apparatus and the gut immune system to the central nervous system. Consequently, the paradigm of the gut-brain axis, which includes the participation of these various factors, has proven a useful model to assist clinicians and patients alike in understanding the genesis of symptoms in IBS...
January 3, 2018: Journal of Clinical Medicine
https://www.readbyqxmd.com/read/29094792/dietary-therapies-for-functional-bowel-symptoms-recent-advances-challenges-and-future-directions
#20
REVIEW
C J Tuck, S J Vanner
BACKGROUND: Functional gastrointestinal symptoms in irritable bowel syndrome (IBS) and quiescent inflammatory bowel disease (IBD) cause significant morbidity and a reduction in quality of life. Multiple dietary therapies are now available to treat these symptoms, but supporting evidence for many is limited. In addition to a further need for studies demonstrating efficacy and mechanism of action of dietary therapies, the risk of nutritional inadequacy, alterations to the microbiome and changes in quality of life are key concerns requiring elucidation...
January 2018: Neurogastroenterology and Motility: the Official Journal of the European Gastrointestinal Motility Society
keyword
keyword
169673
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"